an informa business

“One of the best conferences I’ve seen that addresses the key issues facing the industry as it pertains to Medicaid and other pricing issues.”

22nd ANNUAL

MAY 19-21, 2020 • DISNEY’S CONTEMPORARY RESORT • ORLANDO, FL

Conference Preview

PRICING &CONTRACTING SERIES

A.I and Machine Learning

Bona Fide Service Fees

340B ProgramRebate

Processing

State Pricing

TransparencySupplemental

Rebates

Backed by 21 years of content and industry expertise, the Medicaid and Government Pricing Congress convenes hundreds of executives within the GP community representing

pharmaceutical, biotech, generic and medical device manufacturers. The Congress arms attendees with action-oriented discussions and implementable takeaways led by the

industry’s most authoritative government pricing experts for up-to-the minute insights in an evolving and uncertain regulatory and political landscape.

Gross-to-NetGovernment

Price Reporting

Value-Based

ContractsFederal

Contracting

WHAT TO EXPECT...

M&A

FFS and Managed Medicaid

Biosimilars and High-

Priced Generics

Medicare Part B & D Dispute

Resolution

State Invoicing

CPIU Penalty

State Policy

TAA Compliance

Medicaid Rebate

Processing

AGENDA AT A GLANCEPRE-CONFERENCE SYMPOSIA — TUESDAY, MAY 19, 20208:00 Pre-Conference Summit Registration and Networking Breakfast 9:00 CHOOSE BETWEEN TWO SUMMITS BASED ON LEVEL OF EXPERTISE (A-B)

GOVERNMENT PRICING AND REPORTING 101 BOOT CAMP A SENIOR-LEVEL THINK TANKB12:00 Networking Luncheon3:30 CHOOSE BETWEEN THREE TRACKS BASED ON COMPANY TYPE (1-3)

1:00 Track Chair’s Welcome

1:05 Product Launch Roadmap — Price Reporting Strategies and Considerations

1:45 Blueprint for Establishing Your Product’s Medicaid National Drug Rebate Agreement

2:25 Process and Methodologies for GP System Design and Implementation

1:00 Track Chair’s Welcome

1:05 Technology and Automation Driving GP Efficiencies

1:45 Strategies to Streamline Processes and Expand Commercial and GP Teams

2:25 Innovative Contracting and Bundling

1:00 Track Chair’s Welcome

1:05 CPIU Penalty Impact to Manufacturers 1:45 Medicaid Drug Price Reporting Changes

for Authorized Generics 2:25 Generic Product Launch Approaches

and Considerations

1. SMALL AND EMERGING BIOTECH 2. MID-LARGE PHARMA 3. GENERICS

3:05 Networking and Refreshment Break3:35 CHOOSE BETWEEN THREE TRACKS (4-6)

3:35 Track Chair’s Welcome

3:40 Supplemental Contracting and Claims 4:20 Improve the Efficiency of Medicaid

Rebate Processing 5:00 State Invoice Processing and

Dispute Resolution

3:35 Track Chair’s Welcome

3:40 Country of Origin and Trade Agreement Act Compliance

4:20 Federal Acquisition Regulation Fundamentals for FSS Contractors

5:00 Single vs. Dual Pricing Methodology Strategies and Considerations

3:35 Track Chair’s Welcome

3:40 340B Update — Program Integrity, Compliance and Regulatory Oversight

4:20 Mitigate Duplicate Medicaid and Commercial Rebates

5:00 Refund Processing for New Products and Restatements

4. MEDICAID CLAIMS AND CONTRACT OPERATIONS

5. FEDERAL CONTRACTING AND REPORTING

6. 340B PROGRAM OVERSIGHT AND COMPLIANCE

5:45 Close of Tracks / Welcome Reception Begins

MAIN CONGRESS DAY ONE — WEDNESDAY, MAY 20, 20207:30 Networking Breakfast

8:30 Chair’s Welcome and Opening Remarks

INDUSTRY AND MDRP CRITICAL UPDATES

8:45 State of the Industry — Political and Legislative Trends Impacting Coverage and Access

9:30 OIG Work Plan and 2020 Initiatives

10:15 Networking and Refreshment Break

11:00 HRSA Address — 340B Program Oversight and Initiatives

11:45 PANEL DISCUSSION Navigate Complexities of State Price Transparency and Reporting Requirements

12:30 Networking Luncheon

STATE AND FEDERAL MEDICAID POLICY1:30 LUMINARY ADDRESS Expanding Access to Affordable Healthcare Coverage 2:45 Regulatory Developments and Government Initiatives Impacting the Future of Medicaid

3:30 Networking and Refreshment Break

4:00 CMS Policy Initiatives and Operational Updates

4:45 State Spotlight — Prevailing Trends and Key Factors Impacting State Policy

5:30 Close of Day One / Networking Cocktail Reception Begins

MAIN CONGRESS DAY TWO — THURSDAY, MAY 21, 20208:00 Networking Breakfast

8:30 CHOOSE BETWEEN 3 TRACKS BASED ON FUNCTION (7-9)

8:30 Track Chair’s Welcome8:40 Status of U.S. Territories and Impacts to

Pricing Calculations 9:25 Understand and Integrate Government

Pricing in the Broader Market Access Stream 10:10 Networking and Refreshment Break 10:45 Navigate Evolving Value-Based Contracting

Models and Overcome GP Implications11:30 Trends in Fee-for-Service and Managed

Medicaid

8:30 Track Chair’s Welcome8:40 Ensuring Compliance with State Price

Transparency Reporting 9:25 Electronic Reporting Requirements for

ASP in Part B 10:10 Networking and Refreshment Break 10:45 Bona Fide Service Fees and Fair Market

Value Determination11:30 Strategies for Commercial and

Government Compliance

8:30 Track Chair’s Welcome8:40 Financial Impacts of the Removal of

Coverage Gap 9:25 GTN Models and Best Practices for Forecasts,

Estimates and Accruals 10:10 Networking and Refreshment Break

10:45 PANEL • Evaluate the Importance of Cross-Functional Collaboration of GP, Finance and Compliance

11:30 Best Practices and Analytics to Understand 340B Customer Behavior

7. PRICING, CONTRACTING AND REIMBURSEMENT 8. LEGAL AND COMPLIANCE 9. FINANCE OPERATIONS

12:15 Networking Luncheon

1:45 Legal and Compliance Closing Fireside Chat

3:00 Chair’s Closing Remarks

3:15 Close of Congress

WHO YOU’LL MEET...

NEARLY 350 ATTENDEES

FROM 130 COMPANIES

ANNUAL AUDIENCE:

“Up to the minute updates, informative and great speakers. Conference is great for beginners to experts. I can always

take something from this conference and enjoy the networking opportunities.”

Attendee Profile By Function

62% Pricing/Contracts/Reporting/MDRP

19% Finance/Accounting

12% Managed Markets/Market Access

7% Legal/Compliance

Attendee Profile by Company Size

60% Small

20% Large

12% Upper-Mid

8% Mid

Gary Alexander, President and CEO, The Alexander Group; former Head, Health and Human Services, Commonwealth of Pennsylvania and the State of Rhode Island

Marci Anderson, Auditor, VA Office of Inspector General, Office of Contract Review

Jeffrey Baab, Vice President, Life Sciences, daVIZta, an IntegriChain Company

Mike Benedict, Vice President Operations, Apexus

Steve Benz, Partner, Arnold & Porter

David Berger, Vice President, Legal Affairs, Hikma Pharmaceuticals USA Inc.

Joseph Birdsall, Senior Vice President, Financial Services EVERSANA

Kathleen Black, Director, Government Strategy, Pfizer Inc

Brian Bohnenkamp, Partner, King & Spalding

Mike Borgia, Group Director, Government Channel, Johnson & Johnson

Larry Breen, Director, Financial Planning and Analysis, Sunovion Pharmaceuticals

Lynn Buhl, Director, KPMG LLP

JoAnn Bute, Director, Government Pricing and Compliance, Amneal Pharmaceuticals

David Chan, Co-Founder and CEO, Riparian

Jeff Clayton, Principal, Baker Tilly Virchow Krause, LLP

Lisa Clayton, Director, Government Reporting, Granard Pharmaceuticals

Jonathan Connell, Senior Counsel, Bristol-Myers Squibb

Chris Cobourn, Managing Director, KPMG LLP

Carmela Crimeni, Principal, Cumberland Consulting Group

Jennifer Crosswell, Manager, Government Pricing and Reimbursement, Arbor Pharmaceuticals

Meenakshi Datta, Partner, Sidley Austin LLP

Lenis De León, Senior Manager, Government Pricing and Compliance, Apotex

Rujul Desai, Of Counsel, Covington & Burling LLP

Rajeev Devgan, Director, Government Rebate Operations, Johnson & Johnson Health Care Systems

Susan Dunne, Managing Director, BDO

Aubrey Elmore, Engagement Manager, HighPoint Solutions, an IQVIA Company

Jennifer English, Senior Director, Market Access, Pricing and Gross-to-Net Financial Operations, Insmed Incorporated

Sandy Fischer, Government Pricing Senior Director, Ingenus Pharmaceuticals, LLC

Simon Gisby, Managing Director, Deloitte Corporate Finance LLC

Tanuja Gohil, Associate Director, Government Contracts and Rebates, Novo Nordisk Inc.

Stacey Hale, Drug Rebate Manager, Oklahoma Health Care Authority

Josephine Hawkins, Associate Director, Medicaid, AstraZeneca

Doug Helling, Associate General Counsel, UCB

Kristin Hicks, Partner, Arnold & Porter

Christine Hinds, Policy Analyst, CMS

Marcy Imada, Principal, Deloitte & Touche LLP

Glen Huttar, Director, Government Pricing, Johnson & Johnson Health Care Systems

Murray Kay, Former Senior Vice President and CFO, Solvay Pharmaceuticals; Former Commercial Controller, AbbVie & Abbott Laboratories

Stephanie Kupski, Director, U.S. Pricing and Government Reporting, CSL Behring

Mike Kurland, Vice President, Revenue Management and Compliance Solution, EVERSANA

Michael Kvassay, Social Science Research Analyst, Office of Evaluations and Inspections, OIG

Miree Lee, M.S., MBA, Bio/Pharma Pricing Consultant, M. Lee Consulting, LLC

Lynn Lewis, Director, Data Acquisition and Integrity, IQVIA

Naomi Lopez Bauman, Director, Healthcare Policy, Goldwater Institute

Jennifer Lospinoso, Managing Director, KPMG LLP

Josef Magpantay, Principal, Cumberland Consulting Group

Janice Matasi, Manager, KPMG LLP

Jesse Mendelsohn, Vice President, Centers of Excellence, Model N

Jennifer Woodruff McElhenny, Manager, Baker Tilly Virchow Krause, LLP

Ed McAdam, Director, Government Pricing, Contract Operations and Analytics, Indivior Inc.

Lisa McNair, Senior Manager, Managed Care and Government Pricing, Alvogen

Mark Myers, Director, Healthcare Resources Division, VA Office of Inspector General, Office of Contract Review

Mallory O’Connor, Director, Healthcare Policy and Federal Programs, BIO

Funso Olufade, Ph.D., MBA, Director, U.S. Commercial Finance, Amicus Therapeutics Inc.

Jill Page, Director, Government Pricing Strategy Analysis, Fresenius Medical Care

Andrew Parks, Director, KPMG LLP

Kathleen Peterson, Counsel, Hogan Lovells

Allison Pugsley, Partner, Hogan Lovells

Dorine Rascoe, Fiscal Program Manager, Drug Rebates, Maryland Department of Health

Ron Sandhu, Senior Manager, Deloitte Risk and Financial Advisory, Deloitte & Touche LLP

William Sarraille, Partner, Sidley Austin LLP

Christopher Schott, Partner, Hogan Lovells

Phillip Scott, Senior Vice President, Business Development, NCPDP

John Shakow, Partner, King & Spalding

Brenna Sniderman, Senior Manager, Deloitte Services LLP

James Stansel, Executive Vice President and General Counsel, PhRMA

David Tawes, Regional Inspector General, Department of Health and Human Services, OIG

Michael Tomaselli, Senior Manager, EY

Nicholas Torre, Manager, Riparian

Stephanie Trunk, Partner, Arent Fox LLP

Aaron Vandervelde, Managing Director, BRG

Raquel Villanueva, Senior Manager, Contract Operations, Jazz Pharmaceuticals

Debbie Walters-Francique, Vice President, Assistant General Counsel, Pfizer Inc

Trevor Wear, Partner, Sidley Austin LLP

Donna White, Vice President, Contracts and Compliance, Chiesi USA, Inc.

Greg Wiefel, Director, KPMG LLP

Constance Wilkinson, Member of the Firm, Epstein Becker Green

Cathy Zhang, Associate Director, Government Contracts, Eisai Inc.

Rick Zimmerer, Partner, KPMG LLP

AUTHORITATIVE SPEAKERS DRIVING THE DIALOGUE IN 2019

HOW YOU’LL CONNECT…

an informa business

WWW.CBINET.COM/MEDICAID

Reach Out to the #OrlandoMedicaid Team to Get Involved:

SPEAKING OPPORTUNITIES:

Elise Guerin Saas elise.saas@cbinet.com 339-298-2251

SPONSORSHIP OPTIONS:

Derek Tagliarino derek.tagliarino@cbinet.com 339-298-2206

REGISTRATION & TEAMS:

Christian Alongi christian.alongi@cbinet.com 339-298-2131

Tweet your learnings #orlandomedicaid

Stay Connected and Join the Conversation

Join our LinkedIn Community Medicaid and Government Pricing Network

“The quality of the speakers was outstanding – Informative and insightful!”